Literature DB >> 19417663

Localized immunoglobulin E expression in allergic rhinitis and nasal polyposis.

Sarah K Wise1, Chadwick N Ahn, Rodney J Schlosser.   

Abstract

PURPOSE OF REVIEW: This article reviews recent literature on local tissue identification of immunoglobulin E (IgE) in various sinonasal inflammatory conditions. Discussions of local IgE expression in allergic and nonallergic rhinitis, atopic and nonatopic sinonasal polyposis, and allergic fungal rhinosinusitis are included. RECENT
FINDINGS: Increased levels of IgE and positive reactivity on nasal allergen provocation tests have been demonstrated in nasal lavage fluid of patients with negative systemic allergy testing. In addition, elevated levels of Alternaria alternata-specific IgE have been identified in nasal polyp patients; this is hypothesized as a contributory factor in the development of nasal polyposis. Further evidence supports the role of local IgE to Staphylococcus aureus superantigens in atopic and nonatopic nasal polyposis. Finally, local IgE specific for a range of antigens has been identified in sinus and inferior turbinate tissue in patients with allergic fungal rhinosinusitis.
SUMMARY: Increased levels of IgE have been identified in sinonasal tissues in allergic and nonallergic rhinitis, atopic and nonatopic sinonasal polyposis, and allergic fungal rhinosinusitis. The ability to identify local tissue IgE in inflammatory sinonasal disease states may have significant diagnostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19417663     DOI: 10.1097/MOO.0b013e32832ad23d

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  11 in total

Review 1.  The Role of Allergic Rhinitis in Chronic Rhinosinusitis.

Authors:  Samuel N Helman; Emily Barrow; Thomas Edwards; John M DelGaudio; Joshua M Levy; Sarah K Wise
Journal:  Immunol Allergy Clin North Am       Date:  2020-01-14       Impact factor: 3.479

2.  Molecular patterns in the isotype-specific antibody responses to the major cedar aeroallergen Jun a 1.

Authors:  Randall M Goldblum; Rumali S Madagoda-Desilva; Yueqing Zhang; Julius van Bavel; Terumi Midoro-Horiuti
Journal:  Mol Immunol       Date:  2018-08-29       Impact factor: 4.407

Review 3.  The Role of IgE Production in the Pathophysiology of Rhinitis and Rhinosinusitis.

Authors:  Elizabeth K Hoddeson; Sarah K Wise
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

Review 4.  Perspectives on the etiology of chronic rhinosinusitis.

Authors:  Bruce K Tan; Robert P Schleimer; Robert C Kern
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-02       Impact factor: 2.064

5.  Ubiquitin E3 ligase TNFIAP3 mediates endosome/lysosome fusion in nasal epithelial cells.

Authors:  Xingqiang Gao
Journal:  Mol Cell Biochem       Date:  2012-11-01       Impact factor: 3.396

Review 6.  Omalizumab for severe asthma: efficacy beyond the atopic patient?

Authors:  Christian Domingo
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

7.  Association of IL1β and IL4 gene polymorphisms with nasal polyps in a Polish population.

Authors:  Malgorzata Mrowicka; Hanna Zielinska-Blizniewska; Jaroslaw Milonski; Ireneusz Majsterek; Jurek Olszewski
Journal:  Mol Biol Rep       Date:  2014-03-26       Impact factor: 2.316

8.  Distinct inflammatory profiles in atopic and nonatopic patients with chronic rhinosinustis accompanied by nasal polyps in Western china.

Authors:  Luo Ba; Jintao Du; Feng Liu; Fenglin Yang; Miaomiao Han; Sixi Liu; Ping Lin; Huabin Li
Journal:  Allergy Asthma Immunol Res       Date:  2015-07       Impact factor: 5.764

9.  Differences in airway inflammation according to atopic status in patients with chronic rhinitis.

Authors:  Jae-Woo Kwon; Tae-Wan Kim; Kyung-Mook Kim; Jae-Woo Jung; Sang-Heon Cho; Kyung-Up Min; You-Young Kim; Heung-Woo Park
Journal:  Asia Pac Allergy       Date:  2012-10-31

10.  Update on the management of chronic rhinosinusitis.

Authors:  Rachel B Cain; Devyani Lal
Journal:  Infect Drug Resist       Date:  2013-01-23       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.